<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01856348</url>
  </required_header>
  <id_info>
    <org_study_id>PHA-11-VID/FOL-01</org_study_id>
    <nct_id>NCT01856348</nct_id>
  </id_info>
  <brief_title>Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers</brief_title>
  <official_title>Effects of Vitamin D3 (1,25 Dihydroxyvitamin D3) on Pharmacokinetics and Absorption of Folic Acid and Fexofenadine in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is conducted to assess the effect of a vitamin D3 supplementation on the activities
      of two intestinal transporters and on the pharmacokinetics of the transporter substrates
      folic acid and fexofenadine.

        -  Trial with medicinal product
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ratio of the area under the concentration vs. time curve (AUC) of fexofenadine after vitamin D over AUC of fexofenadine before vitamin D</measure>
    <time_frame>10 days</time_frame>
    <description>Changes in single-dose pharmacokinetics of racemic fexofenadine at the end of a substitution with 1,25 dihydroxyvitamin D3 in comparison to pharmacokinetics before the substitution.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio of Area under the concentration vs. time curve (AUC) of folic acid after vitamin D over AUC of folic acid before vitamin D</measure>
    <time_frame>10 days</time_frame>
    <description>Changes in single-dose pharmacokinetics of folic acid at the end of a substitution with 1,25 dihydroxyvitamin D3 in comparison to pharmacokinetics before the substitution.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and characteristics of participants with adverse events</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>transporter mRNA quantity</measure>
    <time_frame>10 days</time_frame>
    <description>Comparison of transporter mRNA levels after ten days of vitamin D3 intake in comparison to the levels before intake.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Physiological Effects of Vitamin D</condition>
  <arm_group>
    <arm_group_label>1, 25 dihydroxyvitamin D3 intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a single arm study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>1, 25 dihydroxyvitamin D3 intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. male or female

          2. age 18 to 65 years at study entry

          3. signed informed consent form

          4. Body Mass Index &gt; 18 - &lt; 30 kg/m2

          5. Participants must not have any other diseases (as assessed by the screening
             examination)

          6. Participants must not take any concomitant medications except oral contraceptives in
             females

          7. Normal blood count

        Exclusion criteria:

          1. Subjects with confirmed or suspected hypersensitivity towards the study medications

          2. Contemporaneous participation in any other study

          3. Females only: pregnancy

          4. Females only: breast-feeding

          5. Clinically significant abnormal laboratory findings

          6. Known or suspected present or past malignancies of any kind

          7. Known or suspected active infections, serious infections in the preceding 3 months

          8. Positive hepatitis B, hepatitis C and / or HIV 1/2 serology

          9. Subjects known or suspected not to comply with the study regulations

         10. Subjects employed at the participating departments of the University Hospital ZÃ¼rich.

         11. Known or suspected present or past diseases which may interfere with the study

         12. smokers

         13. alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerd A Kullak-Ublick, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Pharmacology and Toxicology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2013</study_first_submitted>
  <study_first_submitted_qc>May 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2013</study_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Dihydroxycholecalciferols</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Fexofenadine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

